Parkinson's disease/Site map

(Redirected from PD Site map)

Each line in the hierarchical Site Map below is in two parts:

The link text as it usually appears in the text and
The link to the page or subpage with its full Wikiversity name.

The User Guide for this Wikiversity learning project is at PD_Wiki_User_Guide edit


The Science Behind Parkinson's - Portal:The_Science_Behind_Parkinson's edit

> Project Development - Portal:The_Science_Behind_Parkinson's/Project_Development
> The six purposes of Section 1 - Portal:The_Science_Behind_Parkinson's/Section 1/more

> Section 1: Progress and Prospects in Parkinson's Research - Progress_and_Prospects_in_Parkinson's_Research edit

> > - Magazine Section - PD_Magazine_Section edit
> Getting the ball rolling - PD_Magazine_Section/Getting_the_ball_rolling
> Hot Topics - PD_Hot_Topics
> Vitamin D - Deficiencies_as_PD_cause/Vitamin_D
> Role of alpha-synuclein in pathogenesis - Current_Parkinson's_Paradigm/Role_of_alpha-synuclein
> Neuroprotective agents - PD_Neuroprotection/Neuroprotective_agents
> Biomarkers and Biomeasures - Monitoring_Parkinson's_Disease
> Induced Pluripotent Stem Cells - Modelling_PD/iPSC
> Genome-Wide Association Studies - PD_Inheritance/GWAS
> Getting Drugs from Lab to Clinic - PD_Research_to_clinic
> > - Researching Parkinson's - Researching_Parkinson's edit
> Modelling Parkinson's - Modelling_PD
> Animal Models - Modelling_PD/Animal_Models
> Rotenone Model - Modelling_PD/Rotenone PD Model
> Induced Pluripotent Stem Cells - Modelling_PD/iPSC
> Hot Topics - PD_Hot_Topics
> Vitamin D - Deficiencies_as_PD_cause/Vitamin_D
> Role of alpha-synuclein in pathogenesis - Current_Parkinson's_Paradigm/Role_of_alpha-synuclein
> Neuroprotective agents - PD_Neuroprotection/Neuroprotective_agents
> Biomarkers and Biomeasures - Monitoring_Parkinson's_Disease
> Induced Pluripotent Stem Cells - Modelling_PD/iPSC
> Genome-Wide Association Studies - PD_Inheritance/GWAS
> Getting Drugs from Lab to Clinic - PD_Research_to_clinic
> > - Causes - PD_Causes edit
> Inheritance - PD_Inheritance
> SNCA - PD_Inheritance/SNCA
> LRRK2 - PD_Inheritance/LRRK2
> MAPT - PD_Inheritance/MAPT
> GBA - PD_Inheritance/GBA
> HLA - PD_Inheritance/HLA
> Trauma - Trauma as PD Cause
> Infection - Infection_as_PD_cause
> Melanoma - Infection_as_PD_cause/Melanoma
> Whooping cough - Infection_as_PD_cause/Whooping cough
> Helicobacter - Infection_as_PD_cause/Helicobacter_pylorii
> Deficiencies
> Blood - Deficiencies_as_PD_cause/Blood
> Glutathione - Deficiencies_as_PD_cause/Glutathione
> Melatonin - Deficiencies_as_PD_cause/Melatonin
> Norepinephrine - Deficiencies_as_PD_cause/Norepinephrine
> Vitamin D - Deficiencies_as_PD_cause/Vitamin_D
> Zinc - Deficiencies_as_PD_cause/Zinc
> Toxins - Toxins_as_PD_cause
> Cadmium - Toxins_as_PD_cause/Cadmium
> Copper - Toxins_as_PD_cause/Copper
> Dieldrin - Toxins_as_PD_cause/Dieldrin
> Manganese - Toxins_as_PD_cause/Manganese
> Maneb - Toxins_as_PD_cause/Maneb
> Mercury - Toxins_as_PD_cause/Mercury
> MPTP - Toxins_as_PD_cause/MPTP
> n-Hexane - Toxins_as_PD_cause/n-Hexane
> Paraquat - Toxins_as_PD_cause/Paraquat
> Rotenone - Toxins_as_PD_cause/Rotenone
> Toluene - Toxins_as_PD_cause/Toluene
> Trichloroethylene - Toxins_as_PD_cause/Trichloroethylene
> Ziram - Toxins_as_PD_cause/Ziram
> > - Pathogenesis - Parkinson's_Pathogenesis edit
> Current Parkinson's Paradigm - Current_Parkinson's_Paradigm
> Working Hypothesis - Current_Parkinson's_Paradigm/Working_Hypothesis
> Emerging Hypotheses - Current_Parkinson's_Paradigm/Emerging_Hypotheses
> Oxidative Stress - Current_Parkinson's_Paradigm/Oxidative_Stress
> Role of alpha-synuclein - Current_Parkinson's_Paradigm/Role_of_alpha-synuclein
> > - Therapy - PD_Therapy edit
> Transplantation - Transplantation_for_PD
> Symptomatic Relief - Symptomatic Relief_for_PD
> Bradykinesia - Symptomatic Relief_for_PD/Bradykinesia
> Dyskinesia - Symptomatic Relief_for_PD/Dyskinesia
> Festination - Symptomatic Relief_for_PD/Festination
> Freezing - Symptomatic Relief_for_PD/Akinesia
> Non-motor symptoms - Symptomatic Relief_for_PD/Non-Motor
> Tremor - Symptomatic Relief_for_PD/Tremor
> Exercise - Exercise_for_PD
> Effect on symptoms - Exercise_for_PD/Effect_on_Symptoms ::::> Neuroprotective effects - Exercise_for_PD/Neuroprotective_effects
> Neuroprotection - PD_Neuroprotection
> Neuroprotective agents - PD_Neuroprotection/Neuroprotective_agents
> Caffeine - PD_Neuroprotection/Caffeine
> Celastrol - PD_Neuroprotection/Celastrol
> Co-enzyme Q10 - PD_Neuroprotection/Co-Enzyme Q10
> Creatine - PD_Neuroprotection/Creatine
> DHA - PD_Neuroprotection/DHA
> Exendin-4 (EX-4) - PD_Neuroprotection/Exendin-4 (EX-4)
> GDNF - PD_Neuroprotection/GDNF
> Glutathione (GSH) - PD_Neuroprotection/Glutathione (GSH)
> GM1 - PD_Neuroprotection/GM1
> Isradipine - PD_Neuroprotection/Isradipine
> Melatonin - PD_Neuroprotection/Melatonin
> Mirapex - PD_Neuroprotection/Mirapex
> Minocycline - PD_Neuroprotection/Minocycline
> Nicotine - PD_Neuroprotection/Nicotine
> NSAIDs - PD_Neuroprotection/NSAIDs
> Phenylbutyrate - PD_Neuroprotection/Phenylbutyrate
> Phytic Acid - PD_Neuroprotection/Phytic Acid
> Quinoxaline - PD_Neuroprotection/Quinoxaline
> Rasagiline - PD_Neuroprotection/Rasagiline
> Riboflavin - PD_Neuroprotection/Riboflavin
> Statins - PD_Neuroprotection/Statins
> Tolcapone - PD_Neuroprotection/Tolcapone
> Urate & Uric Acid - PD_Neuroprotection/Urate & Uric Acid
> Vitamin D - PD_Neuroprotection/Vitamin D
> Vitamin E - PD_Neuroprotection/Vitamin E
> From Lab to Clinic - PD_Research_to_clinic
> Clinical trials and the route to market - PD_Research_to_clinic/The route to market
> > - Monitoring Disease - Monitoring_Parkinson's_Disease edit
> Biomarkers - Biomarkers_for_PD
> Measurement of Disease Progression - Measurement_of_Parkinson's_Disease Progression
> > - Atypical parkinsonism - Atypical_parkinsonism edit
> MSA - Multiple_System_Atrophy
> PSP - Progressive_Supranuclear_Palsy
> DLB - Dementia_with_Lewy_Bodies
> ET - Essential Tremor
> CBD - Corticobasal_Degeneration_(CBD)

> Section 2: Introduction to Parkinson's Science - Introduction_to_Parkinson's_Science edit

> Site Map for Section 2 - Introduction_to_Parkinson's_Science/Site_Map
> > Initial Questions - Introduction_to_Parkinson's_Science/Q_Page_1 edit
> > What causes the motor symptoms? - Introduction_to_Parkinson's_Science/Q_Page_2 edit
> > Why is there not enough dopamine? - Introduction_to_Parkinson's_Science/Q_Page_3 edit